Projects per year
OBJECTIVE The present study investigated atrial-ventricular differences in the
biophysical properties and inhibition by eleclazine of voltage-gated Na+ currents.
METHODS The fast and late components of whole-cell voltage-gated Na+ currents (respectively, INa & INaL) were recorded at room temperature (~22 °C) from rat isolated atrial and ventricular myocytes.
RESULTS Atrial INa activated at command potentials ~5.5 mV more negative and
inactivated at conditioning potentials ~7 mV more negative than ventricular INa. There was no difference between atrial and ventricular myocytes in the eleclazine inhibition of INaL activated by 3 nM ATX-II (IC50s ~200 nM). 10 μM eleclazine inhibited INa in atrial and ventricular myocytes in a use-dependent manner consistent with preferential activated state block. Eleclazine produced voltage-dependent instantaneous inhibition in atrial and ventricular myocytes; it caused a negative shift in voltage of half-maximal inactivation and slowed the recovery of INa from inactivation in both cell types.
CONCLUSIONS Differences exist between rat atrial and ventricular myocytes in the biophysical properties of INa. The more negative voltage-dependence of INa
activation/inactivation in atrial myocytes underlies differences between the two cell types in the voltage-dependence of instantaneous inhibition by eleclazine. Eleclazine warrants further investigation as an atrial-selective anti-arrhythmic drug.
- antiarrhythmic drug
- atrial myocytes
- cardiac regional heterogeneity
- sodium current
- late sodium current
- Na+ channel blocker
- ventricular myocytes
FingerprintDive into the research topics of 'Inhibition of voltage-gated Na+ currents by eleclazine in rat atrial and ventricular myocytes'. Together they form a unique fingerprint.
- 2 Finished
Investigation of pharmacological modulators of TASK-1 K+ channels on electrophysiology of the atrioventricular node.
1/02/17 → 31/01/20
14/03/16 → 13/03/19